Nitric oxide and T helper cell immunity

International Immunopharmacology

Volumn 1, Issue 8, 2001, Pages 1491-1500

  Van Der Veen, Roel C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

EAE; Nitric oxide; Superoxide; T helper cell

Indexed keywords

CYTOKINE; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME ACTIVATION; GENE DELETION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TH1 CELL;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; NITRIC OXIDE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0034929751     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00093-5     Document Type: Review

References (98)

1. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α
2. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells
3. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages
4. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
5. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains
6. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
7. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
8. Local nitric oxide production in viral and autoimmune diseases of the central nervous system
9. Mediation of inflammation by encephalitogenic cells: Interferon γ induction of nitric oxide synthase and cyclooxygenase 2
10. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase
11. Antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice
12. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis
13. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors
14. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis
15. Nitric oxide is a potential down-regulating molecule in autoimmune disease: Inhibition of nitric oxide production renders PVG rats highly susceptible to EAE
16. Oxidant and antioxidant effects of nitric oxide and superoxide in the vasculature
17. IFN-γ receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide
18. NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules
19. Molecular basis of "suppressor" macrophages. Arginine metabolism via the nitric oxide synthetase pathway
20. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents
21. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection
22. Septic mucosal intraepithelial lymphoid immune suppression: Role for nitric oxide not interleukin-10 or transforming growth factor-beta
23. Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T-cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway
24. Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-vs.-host disease
25. Neuronal (type I) nitric oxide synthase regulates nuclear NFκB activity and immunologic (type II) nitric oxide synthase expression
26. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis
27. 2 gene
28. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis
29. Macrophage nitric oxide mediates immunosuppression in infectious inflammation
30. Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: Soluble trypanosome products and interferon-γ are syngergistic inducers of nitric oxide synthase
31. Nitric oxide mediation of active immunosuppression associated with graft-vs.-host reaction
32. Role of nitric oxide in depressed lymphoproliferative responses and altered cytokine production following thermal injury in rats
33. Inheritance of susceptibility to experimental autoimmune encephalomyelitis
34. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice
35. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination
36. Myelin basic protein-specific T-cell clones and experimental allergic encephalomyelitis
37. The development and characterization of encephalitogenic cloned T cells specific for myelin proteolipid protein
38. b mice: Fine specificity and T-cell receptor Vβ expression of encephalitogenic T cells
39. Regulation of T-cell activation: Differences among T-cell subsets
40. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T-cell clones to mediate experimental allergic encephalomyelitis
41. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
42. Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease
43. Interleukin-10 prevents experimental allergic encephalomyelitis in rats
44. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease
45. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice
46. Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced by effector Th1 cells
47. IL-10 fails to abrogate experimental autoimmune encephalomyelitis
48. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyeltis in immunodeficient hosts rather than protect them from the disease
49. Augmentation of an antitumor CTL response in vivo by inhibition of suppressor macrophage nitric oxide
50. Nitric oxide inhibits the proliferation of T helper 1 and 2 lymphocytes without reduction in cytokine secretion
51. + T-cell proliferation and effector function in vivo
52. Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxide in response to self-and alloantigens
53. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon γ, nitric oxide, and apoptosis
54. Macrophage-derived nitric oxide regulates T-cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
55. Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling
56. Cell cycle effects of nitric oxide on vascular smooth muscle cells
57. Nitric oxide modulates expression of cell cycle regulatory proteins. A cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation
58. Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth cells
59. Redox signaling: Nitrosylation and related target interactions of nitric oxide
60. Nitric oxide and thiol groups
61. The ectoenzyme γ-glutamyl transpeptidase regulates antiproliferative effects of S-nitrosoglutathione on human T and B lymphocytes
62. Cell cycle progression of glutathione-depleted human peripheral blood mononuclear cells is inhibited at S phase
63. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-γ
64. Antigen presentation to Th1 but not Th2 cells by macrophages results in nitric oxide production and inhibition of T-cell proliferation; Interferon-γ is essential but insufficient
65. T-cell-mediated cognate signaling of nitric oxide production by macrophages. Requirements for macrophage activation by plasma membranes isolated from T cells
66. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1
67. Impaired T-cell-mediated macropahge activation in CD40 ligand-deficient mice
68. Engagement of major histocompatibility complex class II molecules leads to nitrite production in bone marrow-derived macrophages
69. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells
70. Suppression of cytokine production in T helper type 2 cells by nitric oxide in comparison with T helper type 1 cells
71. Nitric oxide inhibits the secretion of T-helper 1-and T-helper 2-associated cytokines in activated human T cells
72. Superoxide prevents nitric oxide-mediated suppression of helper T lymphocytes: Decreased autoimmune encephalomyelitis in nicotinamide adenine dinucleotide phosphate oxidase knockout mice
73. Macrophage-derived nitric oxide inhibits the proliferation of activated T helper cells and is induced during antigenic stimulation of resting T cells
74. Altered immune responses in mice lacking inducible nitric oxide synthase
75. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages
76. Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction
77. Effects of nitric oxide on the induction and differentiation of Th1 cells
78. IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide
79. Effect of anti-interferon-γ monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains
80. Interferon-gamma confers resistance to experimental allergic encephalomyelitis
81. Failure to suppress the expansion of the activated CD4 T-cell population in interferon-γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis
82. Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy or ageing
83. Effect of splenectomy on the development of experimental autoimmune encephalomyelitis in rats with different genetic background
84. Immunoregulation of passively induced allergic encephalomyelitis
85. Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: Suppressive effects of IL-12 boost are mediated by nitric oxide
86. Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: Inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect
87. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
88. Extensive nitration of protein tyrosines in human atherosclerosis, detected by immunohistochemistry
89. Peroxynitrite-mediated DNA stand breakage activates polyadenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide
90. Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids
91. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis
92. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation
93. Evidence for the production of peroxynitrite in inflammatory CNS demyelination
94. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
95. phox mouse knock-out model of chronic granulomatous disease
96. Regulation of the respiratory burst by cyclic 3′,5′-AMP, association with inhibition of and arachidonic acid release
97. The biochemical basis of the NADPH oxidase of phagocytes
98. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase